Anticancer B
Anticancer B has been studied in 1 paper since 1988: 1 trial in people. The newest paper, Nov 1, 1988: “Spermidine radioimmunoassay in monitor of precancerous lesions of esophagus”.
1 paper studies it1 findingUpdated
“125.1 +/- 72.9 ng/ml in 62 patients with MEH treated by Anticancer B”
- 1 lab in 1 country
- Human trial1
Studies in people
1 study gave anticancer B to people and measured what changed.
down: Decreases serum spermidine125.1 vs 162.4 ng/ml in controls
Trial62 peopleone year
General population; one year after treatment, compared with placebo controls
Zhonghua zhong liu za zhi [Chinese journal of oncology], Nov 1, 1988
What did studies of Anticancer B find?
1Studies of Anticancer B measured 1 outcome; the most studied are serum spermidine (1 study).
Serum spermidine
downin humans1
1 study
Serum spermidine
downin humans1
Anticancer B decreases serum spermidine in humans (one year after treatment, compared with placebo controls) (125.1 vs 162.4 ng/ml in controls).
“125.1 +/- 72.9 ng/ml in 62 patients with MEH treated by Anticancer B”
Human trialone year after treatment, compared with placebo controlsone yearn = 62
Spermidine radioimmunoassay in monitor of precancerous lesions of esophagus
Zhonghua zhong liu za zhi [Chinese journal of oncology]